ArticleCEUR workshop proceedings.
Ontology-based representation and analysis of conditional vaccine immune responses using Omics data.
Article in CEUR workshop proceedings.. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- SEA CDM: Study-Experiment-Assay Common Data Model and Databases for Cross-Domain Data Integration and Analysis.Scientific data · 2026Article
- VO: The Vaccine Ontology.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
ImmPort, the world's largest repository of immunology data, includes many vaccine immune response datasets. ImmPort maps the metadata of these studies to ontology and database schema. As of February 28, 2023, our ImmPort data analysis identified 6.258 immune exposures using 47 vaccines in 4,607 human subjects, and 324 cohort studies from the ImmPort. We hypothesized that an integrative ontological representation of the data from these studies would enhance our understanding and analysis of these ImmPort vaccine studies, and with ontological classification and tools such as VIGET, we could further study the effects of different conditions such as vaccine types and host biological sex on the vaccine response gene expression profiles. Our Vaccine Ontology (VO) analysis classified these 37 vaccines into bacterial, viral, and protozoan vaccine types with different vaccine properties. The ImmPort metadata types were modeled with the Vaccine Investigation Ontology (VIO). Our new ontology-based pipeline extracted vaccine response data from the ImmPort database, annotated them based on ontology, obtained corresponding gene expression data from the GEO, and performed consistent omics data analysis. Our use case found gene profiles shared and differed from live and killed inactivated influenza vaccines. Furthermore, our Omics data analysis using the VIGET tool found that female and male human subjects have differential host responses for influenza vaccines. For example, our study showed much stronger early female responses to influenza vaccination than males, and males was able to show active immune responses at a later stage. Interestingly, the female (but not male) human subject group also showed significantly enriched neutrophil degranulation at Day 3 after influenza vaccination; however, males (but not females) displayed significantly enriched neutrophil degranulation at Day 14 after influenza vaccination. These mechanisms have been used to find differences between the gene lists and pathways of host responses to different vaccines conditional to different factors including vaccine types and host biological sex. Moreover, this framework can be expanded to other vaccines and vaccine categories easily.
Indexed as
Identifiers
39583065PMC11584146What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.